# Saquinavir/Ritonavir in Single Therapy as Maintenance Treatment

> **NCT00379405** · PHASE4 · COMPLETED · sponsor: **Germans Trias i Pujol Hospital** · enrollment: 30 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Saquinavir/Ritonavir : 2 capsules (500 mg) / 12 hours

## Key facts

- **NCT ID:** NCT00379405
- **Lead sponsor:** Germans Trias i Pujol Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2008-05
- **Final completion:** 2008-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00379405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00379405, "Saquinavir/Ritonavir in Single Therapy as Maintenance Treatment". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00379405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*